Journal
RSC ADVANCES
Volume 12, Issue 31, Pages 20264-20295Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2ra03434d
Keywords
-
Categories
Funding
- VIT
- DST-SERB CRG grant [CRG/2021/002267]
Ask authors/readers for more resources
Metal complexes, especially rhenium-based complexes, have attracted global interest as potential cancer therapeutics due to their ability to detect and annihilate cancer cells.
Metal complexes have gradually been attracting interest from researchers worldwide as potential cancer therapeutics. Driven by the many side effects of the popular platinum-based anticancer drug cisplatin, the tireless endeavours of researchers have afforded strategies for the design of appropriate metal complexes with minimal side effects compared to cisplatin and its congeners to limit the unrestricted propagation of cancer. In this regard, transition metal complexes, especially rhenium-based complexes are being identified and highlighted as promising cancer theranostics, which are endowed with the ability to detect and annihilate cancer cells in the body. This is attributed the amazing photophysical properties of rhenium complexes together with their ability to selectively attack different organelles in cancer cells. Therefore, this review presents the properties of different rhenium-based complexes to highlight their recent advances as anticancer agents based on their cytotoxicity results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available